en
Scientific article
Case report
English

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A

Published inActa ophthalmologica, vol. 87, no. 8, p. 930-932
Publication date2009
Keywords
  • Angiogenesis Inhibitors/*administration & dosage
  • Antibodies, Monoclonal/*administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Female
  • Fovea Centralis/*blood supply
  • Humans
  • Injections, Intraocular
  • Middle Aged
  • Retinal Neovascularization/*drug therapy/*etiology
  • Telangiectasis/classification/*complications
  • Vitreous Body
Citation (ISO format)
MAVRAKANAS, Nikolaos et al. Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A. In: Acta ophthalmologica, 2009, vol. 87, n° 8, p. 930–932. doi: 10.1111/j.1755-3768.2009.01598.x
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal1755-375X
458views
0downloads

Technical informations

Creation04/23/2012 1:24:16 PM
First validation04/23/2012 1:24:16 PM
Update time03/14/2023 5:26:01 PM
Status update03/14/2023 5:26:01 PM
Last indexation02/12/2024 8:01:20 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack